An assessment of vocal impairment is presented for separating healthy people from persons with early untreated Parkinson’s disease (PD). This study’s main purpose was to (a) determine whether voice and speech disorder are present from early stages of PD before starting dopaminergic pharmacotherapy, (b) ascertain the specific characteristics of the PD-related vocal impairment, (c) identify PD-related acoustic signatures for the major part of traditional clinically used measurement methods with respect to their automatic assessment, and (d) design new automatic measurement methods of articulation. The varied speech data were collected from 46 Czech native speakers, 23 with PD. Subsequently, 19 representative measurements were pre-selected, and Wald sequential analysis was then applied to assess the efficiency of each measure and the extent of vocal impairment of each subject. It was found that measurement of the fundamental frequency variations applied to two selected tasks was the best method for separating healthy from PD subjects. On the basis of objective acoustic measures, statistical decision-making theory, and validation from practicing speech therapists, it has been demonstrated that 78% of early untreated PD subjects indicate some form of vocal impairment. The speech defects thus uncovered differ individually in various characteristics including phonation, articulation, and prosody.

1.
O.
Hornykiewicz
, “
Biochemical aspects of Parkinson’s disease
,”
Neurol. Suppl.
51
(
2
),
S2
S9
(
1998
).
2.
M. C.
de Rijk
,
L. J.
Launer
,
K.
Berger
,
M. M. B.
Breteler
,
J. -F.
Dartigues
,
M.
Baldereschi
,
L.
Fratiglioni
,
A.
Lobo
,
J.
Martinez-Lage
,
C.
Trenkwalder
, and
A.
Hofman
, “
Prelevance of Parkinson’s disease in Europe: A collaborative study of population-based cohorts
,”
Neurology
54
,
21
23
(
2000
).
3.
A.
Lang
and
A.
Lozano
, “
Parkinson’s disease: First of two parts
,”
New Engl. J. Med.
339
,
1044
1053
(
1998
).
4.
M.
Hoehn
, “
The natural history of Parkinson’s disease in the pre-levodopa and post-levodopa eras
,”
Neurol. Clin.
10
,
331
339
(
1992
).
5.
M. C.
de Rijk
,
C.
Tzourio
,
M. M.
Breteler
,
J. F.
Dartiques
,
L.
Amaducci
,
S.
Lopez-Pousa
,
J. M.
Manubens-Bertran
,
A.
Alpérovitch
, and
W. A.
Rocca
, “
Prevalence of parkinsonism and Parkinson’s disease in Europe: The EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease
,”
J. Neurol. Neurosurg. Psychiatry
62
,
10
15
(
1997
).
6.
S. K.
Van Den Eeden
,
C. M.
Tanner
,
A. L.
Bernstein
,
R. D.
Fross
,
A.
Leimpeter
,
D. A.
Bloch
, and
L. M.
Nelson
, “
Incidence of Parkinson’s disease: Variation by age, gender, and race/ethnicity
,”
Am. J. Epidemiol.
157
,
1015
1022
, (
2003
).
7.
G. J.
Canter
, “
Speech characteristic of patients with Parkinson’s disease. I. Intensity, pitch, and duration
,”
J. Speech Hear. Disord.
28
,
221
229
(
1963
).
8.
F. L.
Darley
,
A. E.
Aronson
, and
J. R.
Brown
, “
Differential diagnostic patterns of dysarthria
,”
J. Speech. Hear. Res.
12
,
426
496
(
1969
).
9.
A. K.
Ho
,
R.
Iansek
,
C.
Marigliani
,
J.
Bradshaw
, and
S.
Gates
, “
Speech impairment in large sample of patients with Parkinson’s disease
,”
Behav. Neurol.
11
,
131
137
(
1998
).
10.
J. A.
Logemann
,
H. B.
Fisher
,
B.
Boshes
, and
E. R.
Blonsky
, “
Frequency and coocurrence of vocal tract dysfunction in the speech of a large sample of Parkinson patients
,”
J. Speech Hear. Disord.
43
,
47
57
(
1978
).
11.
J. R.
Duffy
,
Motor Speech Disorders: Substrates, Differential Diagnosis and Management
, 2nd ed. (
Mosby
,
New York, NY
,
2005
), pp.
1
592
.
12.
B.
Harel
,
M.
Cannizzaro
, and
P. J.
Snyder
, “
Variability in fundamental frequency during speech in prodromal and incipient Parkinson’s disease: A longitudinal case study
,”
Brain Cogn.
56
,
24
29
(
2004
).
13.
N.
Singh
,
V.
Pillay
, and
Y. E.
Choonara
, “
Advances in the treatment of Parkinson’s disease
,”
Prog. Neurobiol.
81
,
29
44
(
2007
).
14.
J.
King
,
L.
Ramig
,
J. H.
Lemke
, and
Y.
Horii
, “
Parkinson’s disease: Longitudinal changes in acoustic parameters of phonation
,”
J. Med. Speech Lang. Pathol.
2
,
29
42
(
1994
).
15.
M.
Trail
,
C.
Fox
,
L. O.
Ramig
,
S.
Sapir
,
J.
Howard
, and
E. C.
Lai
, “
Speech treatment for Parkinson’s disease
,”
Neurorehabilitation
20
,
205
221
(
2005
).
16.
A. M.
Goberman
and
M.
Blomgren
, “
Parkinsonian speech disfluencies: Effects of L-dopa-related fluctuation
,”
J. Fluency Disord.
28
,
55
70
(
2003
).
17.
M.
Putzer
,
W. J.
Barry
, and
J. R.
Moringlane
, “
Effect of bilateral stimulation of the subthalamic nucleus on different speech subsystems in patients with Parkinson’s disease
,”
Clin. Linguist. Phonetics
22
,
957
973
(
2008
).
18.
A. K.
Ho
,
J. L.
Bradshaw
, and
R.
Iansek
, “
For better or worse: The effect of levodopa on speech in Parkinson’s disease
,”
Mov. Disord.
23
,
574
580
(
2007
).
19.
M.
Oxtoby
,
Parkinson’s Disease People and Their Social Needs
(
Parkinson’s Disease Society
,
London, United Kingdom
,
1982
), pp.
1
75
.
20.
S.
Sapir
,
L. O.
Ramig
,
P.
Hoyt
,
S.
Countryman
,
C.
O’Brien
, and
M.
Hoehn
, “
Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson’s disease: A comparison with an alternative speech treatment
,”
Folia Phoniatr. Logop.
54
,
296
303
(
2002
).
21.
D. M.
Huse
,
K.
Schulman
,
L.
Orsini
,
J.
Castelli-Haley
,
S.
Kennedy
, and
G.
Lenhart
, “
Burden of illness in Parkinson’s disease
,”
Mov. Disord.
20
,
1449
1454
(
2005
).
22.
B. T.
Harel
,
M. S.
Cannizaro
,
H.
Cohen
,
N.
Reilly
, and
P. J.
Snyder
, “
Acoustic characteristic of Parkinsonian speech: A potential biomarker of early disease progression and treatment
,”
J. Neurolinguistics
17
,
439
453
(
2004
).
23.
M. A.
Little
,
P. E.
McSharry
,
E. J.
Hunter
,
J.
Spielman
, and
L. O.
Ramig
, “
Suitability of dysphonia measurement for telemonitoring of Parkinson’s disease
,”
IEEE Trans. Biomed. Eng.
56
,
1015
1022
(
2009
).
24.
C.
Ruggiero
,
R.
Sacile
, and
M.
Giacomini
, “
Home telecare
,”
J. Telemed. Telecare
5
,
11
17
(
1999
).
25.
F. L.
Darley
,
A. E.
Aronson
,
J. R.
Brown
,
Motor Speech Disorders
(
Saunders
,
Philadelphia, PA
,
1975
), pp.
1
305
.
26.
C.
Ludlow
,
N.
Connor
, and
C.
Bassich
, “
Speech timing in Parkinson’s and Huntingston’s disease
,”
Brain Lang.
32
,
195
214
(
1987
).
27.
P.
Zwirner
, and
G.
Barnes
, “
Vocal tract steadiness: A measure of phonatory stability and upper airway motor control during phonation in dysarthria
,”
J. Speech Hear. Res.
35
,
761
768
(
1992
).
28.
A. M.
Goberman
and
C.
Coelho
, “
Acoustic analysis of Parkinsonian speech I: Speech characteristics and L-dopa therapy
,”
Neurorehabilitation
17
,
237
246
(
2002
).
29.
R. J.
Holmes
,
J. M.
Oates
,
D. J.
Phyland
, and
A. J.
Hughes
, “
Voice characteristics in the progression of Parkinson’s disease
,”
Int. J. Lang. Commun. Disord.
35
,
407
418
(
2000
).
30.
S.
Skodda
, and
U.
Schlegel
, “
Speech rate and rhythm in Parkinson’s disease
,”
Mov. Disord.
23
,
985
992
(
2008
).
31.
P. J.
Watson
and
B.
Munson
, “
Parkinson’s disease and the effect of lexical factors on vowel articulation
,”
J. Acoust. Soc. Am.
124
,
291
295
(
2008
).
32.
J. I.
Godino-Llorente
and
P.
Gomez-Vilda
, “
Automatic detection of voice impairments by means of short-term cepstral parameters and neural network based detectors
,”
IEEE Trans. Biomed. Eng.
51
,
380
384
(
2004
).
33.
P.
Henriquez
,
J. B.
Alonso
,
M. A.
Ferrer
,
C. M.
Travieso
,
J. I.
Godino-Llorente
, and
F.
Diaz-de-Maria
, “
Characterization of healthy and pathological voice through measures based on nonlinear dynamics
,”
IEEE Trans. Audio, Speech, Lang. Process.
17
,
1186
1195
(
2009
).
34.
D. A.
Rahn
,
M.
Chou
,
J. J.
Jiang
, and
Y.
Zhang
, “
Phonatory impairment in Parkinson’s disease: Evidence from nonlinear dynamics analysis and perturbation analysis
,”
J. Voice
21
,
64
71
(
2007
).
35.
M. I.
Schlesinger
and
V.
Hlavac
, “
Ten lectures on statistical and structural pattern recognition
,” in
Volume 24 of Computational Imaging and Vision
(
Kluwer Academic Press
,
Dordrecht
,
2002
), pp.
1
544
.
36.
M.
Hoehn
and
M.
Yahr
, “
Parkinsonism: Onset, progression and mortality
,”
Neurology
17
,
427
442
(
1967
).
37.
G.
Stebbing
and
C.
Goetz
, “
Factor structure of the Unified Parkinson’s Disease Rating Scale: Motor Examination Section
,”
Mov. Disord.
13
,
633
636
(
1998
).
38.
L.
Ramig
,
S.
Countryman
,
L.
Thompson
, and
Y.
Horii
, “
Comparison of two forms of intensive treatment for Parkinson disease
,”
J. Speech Hear. Res.
38
,
1232
1251
(
1995
).
39.
A. M.
Goberman
, “
Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson disease
,”
Med. Sci. Monit.
11
,
109
116
(
2005
).
40.
R. J.
Baken
, and
R. F.
Orlikoff
,
Clinical Measurement of Speech and Voice
, 2nd ed. (
Singular Thomson Learning
,
San Diego, CA
,
2000
), pp.
1
610
.
41.
L.
Lisker
and
A.
Abrason
, “
A cross-language study of voicing in initial stops: Acoustical measurements
,”
Word
20
,
384
442
(
1964
).
42.
K.
Forrest
,
G.
Weismer
, and
G.
Turner
, “
Kinematic, acoustic and perceptual analyses of connected speech produced by Parkinsonian and normal geriatric males
,”
J. Acoust. Soc. Am.
85
,
2608
2622
(
1989
).
43.
G.
Weismer
, “
Articulatory characteristics of Parkinsonian dysarthria: Segmental and phrase-level timing, spirantization, and glottal-supraglottal coordination
,” in
The Dysarthrias: Physiology, Acoustics, Perception, Management
, edited by
M.
Mcneil
,
J.
Rosenbeck
, and
A.
Aronson
(
College-Hill Press
,
San Diego, CA
,
1984
), pp.
101
130
.
44.
J.
Logemann
and
H.
Fisher
, “
Vocal tract control in Parkinson’s disease: Phonetics feature analysis of misartriculation
,”
J. Speech. Hear. Disord.
46
,
348
352
(
1981
).
45.
S.
Fletcher
, “
Time-by-count measurement of diadochokinetic syllable rate
,”
J. Speech. Hear. Disord.
15
,
757
762
(
1972
).
46.
L.
D’Alatri
,
G.
Paludett
,
M. F.
Contarino
,
S.
Galla
,
M. R.
Marchese
, and
A. R.
Bentivoglio
, “
Effects of bilateral subthalamic nucleus stimulation and medication on Parkinsonian speech impairment
,”
J. Voice
22
,
365
372
(
2008
).
47.
G.
Weismer
,
J. -Y.
Jeg
,
J. S.
Laures
,
R. D.
Kent
, and
J. F.
Kent
, “
Acoustic and intelligibility characteristic of sentence production in neurogenic speech disorders
,”
Folia Phoniatr. Logop.
53
,
1
18
(
2001
).
48.
K.
Tjaden
, “
Anticipatory coarculation in multiple sclerosis and Parkinson’s disease
,”
J. Speech Lang. Hear. Res.
46
,
990
1008
(
2003
).
49.
J.
Metter
and
W.
Hanson
, “
Clinical and acoustical variability in hypokinetic dysarthria
,”
J. Commun. Disord.
19
,
347
366
(
1986
).
50.
A. P.
Simpson
, “
Phonetic differences between male and female speech
,”
Lang. Linguist. Compass
3/2
,
621
640
(
2009
).
51.
B. C. J.
Moore
,
An Introduction to the Psychology of Hearing
, 5th ed. (
Academic Press
,
Boston
,
2003
), pp.
1
413
.
52.
J.
Mobes
,
G.
Joppich
,
F.
Stiebritz
,
R.
Dengler
, and
Ch.
Schroder
, “
Emotional speech in Parkinson’s disease
,”
Mov. Disord.
23
,
824
829
(
2008
).
53.
H.
Boril
and
P.
Pollak
, “
Direct time domain fundamental estimation of speech in noisy conditions
,” in
EUROSIPCO Proceedings
,
Vienna, Austria
(
2004
), pp.
1003
1006
.
54.
B.
Kotnik
,
H.
Hoge
,
Z.
Kacic
, “
Noise robust F0 determination and epoch-marking algorithms
,”
Signal Process.
89
,
2555
2569
(
2009
).
55.
X.
Wei
,
L.
Zhao
,
Q.
Zhang
,
J.
Dong
, “
Robust pitch estimation using a wavelet variance analysis model,” Signal Process.
89
,
1216
1223
(
2009
).
56.
P.
Boersma
and
D.
Weenink
, “
PRAAT, a System for Doing Phonetics by Computer
,”
Glot Int.
5
,
341
345
(
2001
).
57.
A.
Novak
and
J.
Vokral
, “
Acoustic parameters for the evaluation of voice of future voice professionals
,”
Folia Phoniatr. Logop.
47
,
279
285
(
1995
).
58.
P.
Boersma
, “
Accurate short-term analysis of the fundamental frequency and harmonics-to-noise ratio of a sampled sound
,” in
Proceedings of the Institute of Phonetics Sciences
,
Amsterdam, The Netherlands
, vol.
17
(
1993
), pp.
97
110
.
59.
J.
Rusz
and
R.
Cmejla
, “
Speech rate and intensity analysis in Parkinson’s disease
,”
(in Czech), Akusticke listy
14
,
13
17
(
2008
).
60.
C.
Ozsancak
,
P.
Auzou
,
M.
Jan
, and
D.
Hannequin
, “
Measurements of voice onset time in dysarthric patients: Methodological consideration
,”
Folia Phoniatr. Logop.
53
,
48
57
(
2001
).
61.
E.
Fisher
and
A. M.
Goberman
, “
Voice onset time in Parkinson disease
,”
J. Commun. Disord.
43
,
21
34
(
2010
).
62.
K.
Mustafa
and
I. C.
Bruce
, “
Robust formant tracking for continuous speech with speaker variability
,”
IEEE Trans. Audio, Speech, Lang. Process.
14
,
435
444
(
2006
).
63.
H.
Sakoe
and
S.
Chiba
, “
Dynamic programming algorithm optimization for spoken word recognition
,”
IEEE Trans. Acoust. Speech Signal Process.
26
,
43
49
(
1978
).
64.
D.
Duez
, “
Acoustic analysis of occlusive weakening in Parkinsonian French speech
,” in
Processing of International Congress of Phonetic Sciences
,
Saarbrucken
,
Germany
(
2007
), pp.
1973
1976
.
65.
P. W.
Holland
, and
R. E.
Welsch
, “
Robust regression using iteratively reweighted least-squares
,”
Commun. Stat: Theory Meth.
42
,
152
154
(
1988
).
66.
R.
Cmejla
and
P.
Sovka
, “
Recursive Bayesian autoregressive changepoint detector for sequential signal segmentation
,” in
EUROSIPCO Proceedings
,
Wien
(
2004
), pp.
245
248
.
67.
J. J. K.
O. Ruanaidh
and
W. J.
Fitzgerald
,
Numerical Bayesian Methods Applied to Signal Processing
(
Springer-Verlag
,
New York, NY
,
1996
), pp.
1
254
.
68.
P.
Bergl
and
R.
Cmejla
, “
Improved detection of phonemes in speech databases
,” in
Proceedings of the Fifth IAESTED International Conference on Biomedical Engineering
(
Innsbruck
,
2007
), pp.
171
174
.
69.
A.
Wald
,
Sequential Analysis
(
Wiley
,
New York, NY
,
1947
), pp.
1
209
.
70.
J.
Neyman
and
E. S.
Pearson
, “
On the use and interpretation of certain test criteria for purposes of statistical inference
,”
Biometrika
20A
,
175
240
, 263–294 (
1928
).
71.
A. W.
Bowman
and
A.
Azzalini
,
Applied Smoothing Techniques for Data Analysis
(
Oxford University Press
,
Oxford, United Kingdom
,
1997
), pp.
1
208
.
You do not currently have access to this content.